{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T03:24:36Z","timestamp":1771644276074,"version":"3.50.1"},"reference-count":75,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"vor","delay-in-days":731,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.rmed.2019.04.001","type":"journal-article","created":{"date-parts":[[2019,4,3]],"date-time":"2019-04-03T22:09:06Z","timestamp":1554329346000},"page":"43-48","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Bronchodilators in subjects with asthma-related comorbidities"],"prefix":"10.1016","volume":"151","author":[{"given":"Mario","family":"Cazzola","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Rogliani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0456-069X","authenticated-orcid":false,"given":"Luigino","family":"Calzetta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Gabriella","family":"Matera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.rmed.2019.04.001_bib1","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/MCP.0b013e32835b113a","article-title":"Comorbidities of asthma: current knowledge and future research needs","volume":"19","author":"Cazzola","year":"2013","journal-title":"Curr. Opin. Pulm. Med."},{"key":"10.1016\/j.rmed.2019.04.001_bib2","author":"Global Initiative for Asthma"},{"issue":"1","key":"10.1016\/j.rmed.2019.04.001_bib3","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1183\/09031936.00140310","article-title":"Asthma and comorbid medical illness","volume":"38","author":"Cazzola","year":"2011","journal-title":"Eur. Respir. J."},{"issue":"2","key":"10.1016\/j.rmed.2019.04.001_bib4","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.rmed.2011.07.021","article-title":"Cardiovascular disease in asthma and COPD: a population-based retrospective cross-sectional study","volume":"106","author":"Cazzola","year":"2012","journal-title":"Respir. Med."},{"issue":"10","key":"10.1016\/j.rmed.2019.04.001_bib5","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1080\/17425255.2018.1530215","article-title":"Pharmacokinetic considerations concerning the use of bronchodilators in the treatment of chronic obstructive pulmonary disease","volume":"14","author":"Matera","year":"2018","journal-title":"Expert Opin. Drug Metabol. Toxicol."},{"issue":"1","key":"10.1016\/j.rmed.2019.04.001_bib6","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2165\/00003088-200241010-00003","article-title":"Clinical pharmacokinetics of salmeterol","volume":"41","author":"Cazzola","year":"2002","journal-title":"Clin. Pharmacokinet."},{"issue":"12","key":"10.1016\/j.rmed.2019.04.001_bib7","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.2165\/00003495-200565120-00001","article-title":"Inhaled \u03b22-adrenoceptor agonists: cardiovascular safety in patients with obstructive lung disease","volume":"65","author":"Cazzola","year":"2005","journal-title":"Drugs"},{"issue":"3","key":"10.1016\/j.rmed.2019.04.001_bib8","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.pupt.2012.12.006","article-title":"Long-acting muscarinic receptor antagonists for the treatment of respiratory disease","volume":"26","author":"Cazzola","year":"2013","journal-title":"Pulm. Pharmacol. Therapeut."},{"issue":"42","key":"10.1016\/j.rmed.2019.04.001_bib9","article-title":"Impact of asthma on the development of coronary vasospastic angina: a population-based cohort study","volume":"94","author":"Hung","year":"2015","journal-title":"Medicine (Baltim.)"},{"issue":"1","key":"10.1016\/j.rmed.2019.04.001_bib10","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jaci.2008.10.032","article-title":"Cardiovascular disease risk associated with asthma and respiratory morbidity might be mediated by short-acting beta2-agonists","volume":"123","author":"Appleton","year":"2009","journal-title":"J. Allergy Clin. Immunol."},{"issue":"2\u20133","key":"10.1016\/j.rmed.2019.04.001_bib11","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0167-5273(02)00369-8","article-title":"Characterisation of isoprenaline myotoxicity on slow-twitch skeletal versus cardiac muscle","volume":"86","author":"Ng","year":"2002","journal-title":"Int. J. Cardiol."},{"issue":"6","key":"10.1016\/j.rmed.2019.04.001_bib12","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1378\/chest.101.6.1699","article-title":"Sudden cardiac death in bronchial asthma, and inhaled beta-adrenergic agonists","volume":"101","author":"Robin","year":"1992","journal-title":"Chest"},{"key":"10.1016\/j.rmed.2019.04.001_bib13","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1378\/chest.121.3.846","article-title":"Association between inhaled beta-agonists and the risk of unstable angina and myocardial infarction","volume":"121","author":"Au","year":"2002","journal-title":"Chest"},{"key":"10.1016\/j.rmed.2019.04.001_bib14","doi-asserted-by":"crossref","first-page":"163","DOI":"10.2147\/COPD.S1516","article-title":"Cardiovascular morbidity and the use of inhaled bronchodilators","volume":"3","author":"Macie","year":"2008","journal-title":"Int. J. Chronic Obstr. Pulm. Dis."},{"issue":"5","key":"10.1016\/j.rmed.2019.04.001_bib15","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1046\/j.1365-2796.1998.00291.x","article-title":"Salbutamol inhalation has no effect on myocardial ischaemia, arrhythmias and heart-rate variability in patients with coronary artery disease plus asthma or chronic obstructive pulmonary disease","volume":"243","author":"Rossinen","year":"1998","journal-title":"J. Intern. Med."},{"issue":"7","key":"10.1016\/j.rmed.2019.04.001_bib16","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1097\/HJH.0b013e32832af68d","article-title":"The pattern of risk of myocardial infarction in patients taking asthma medication: a study with the general practice research database","volume":"27","author":"Zhang","year":"2009","journal-title":"J. Hypertens."},{"issue":"7","key":"10.1016\/j.rmed.2019.04.001_bib17","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1097\/HJH.0b013e32832c4e06","article-title":"Shortness of breath, prescription of bronchodilators and the risk of myocardial infarction","volume":"27","author":"Squire","year":"2009","journal-title":"J. Hypertens."},{"issue":"2","key":"10.1016\/j.rmed.2019.04.001_bib18","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.ijcard.2014.07.087","article-title":"The association of asthma and atrial fibrillation - a nationwide population-based nested case-control study","volume":"176","author":"Chan","year":"2014","journal-title":"Int. J. Cardiol."},{"issue":"6","key":"10.1016\/j.rmed.2019.04.001_bib19","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1378\/chest.125.6.2309","article-title":"Cardiovascular effects of beta-agonists in patients with asthma and COPD: a meta-analysis","volume":"125","author":"Salpeter","year":"2004","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.rmed.2019.04.001_bib20","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.ejcdt.2014.03.010","article-title":"A study of electrolyte disturbances in patients with chronic stable asthma and with asthma attacks","volume":"63","author":"Mohammad","year":"2014","journal-title":"Egypt. J. Chest Dis. Tuberc."},{"issue":"8","key":"10.1016\/j.rmed.2019.04.001_bib21","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1001\/jamacardio.2018.1901","article-title":"Associations of asthma and asthma control with atrial fibrillation risk: results from the Nord-Tr\u00f8ndelag Health Study (HUNT)","volume":"3","author":"Cepelis","year":"2018","journal-title":"JAMA Cardiol."},{"issue":"6","key":"10.1016\/j.rmed.2019.04.001_bib22","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1378\/chest.105.6.1701","article-title":"Effects of aerosol ipratropium bromide on cardiac vagal tone","volume":"105","author":"Lehrer","year":"1994","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.rmed.2019.04.001_bib23","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/phar.1336","article-title":"Risk of arrhythmias associated with ipratropium bromide in children, adolescents, and young adults with asthma: a nested case-control study","volume":"34","author":"Adimadhyam","year":"2014","journal-title":"Pharmacotherapy"},{"issue":"6","key":"10.1016\/j.rmed.2019.04.001_bib24","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1378\/chest.99.6.1415","article-title":"The arrhythmogenicity of theophylline. A multivariate analysis of clinical determinants","volume":"99","author":"Bittar","year":"1991","journal-title":"Chest"},{"key":"10.1016\/j.rmed.2019.04.001_bib25","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.pupt.2018.09.007","article-title":"Impact of doxofylline compared to theophylline in asthma: a pooled analysis of functional and clinical outcomes from two multicentre, double-blind, randomized studies (DOROTHEO 1 and DOROTHEO 2)","volume":"53","author":"Calzetta","year":"2018","journal-title":"Pulm. Pharmacol. Therapeut."},{"issue":"1","key":"10.1016\/j.rmed.2019.04.001_bib26","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1378\/chest.90.1.45","article-title":"Cardiac arrhythmias during the combined use of \u03b2-adrenergic agonist drugs and theophylline","volume":"90","author":"Coleman","year":"1986","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.rmed.2019.04.001_bib27","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1378\/chest.94.3.496","article-title":"Cardiac arrhythmias during the combined use of intravenous aminophylline and terbutaline in status asthmaticus","volume":"94","author":"Laaban","year":"1988","journal-title":"Chest"},{"issue":"824","key":"10.1016\/j.rmed.2019.04.001_bib28","first-page":"309","article-title":"Hypokalaemic and electrocardiographic effects of aminophylline and salbutamol in obstructive airways disease","volume":"100","author":"Crane","year":"1987","journal-title":"N. Z.Med. J."},{"issue":"5","key":"10.1016\/j.rmed.2019.04.001_bib29","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.ahj.2004.03.048","article-title":"Association between chronic heart failure and inhaled \u03b2-2-adrenoceptor agonists","volume":"148","author":"Au","year":"2004","journal-title":"Am. Heart J."},{"issue":"8","key":"10.1016\/j.rmed.2019.04.001_bib30","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1093\/eurjhf\/hfr063","article-title":"Are beta2-agonists responsible for increased mortality in heart failure?","volume":"13","author":"Bermingham","year":"2011","journal-title":"Eur. J. Heart Fail."},{"issue":"4","key":"10.1016\/j.rmed.2019.04.001_bib31","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1054\/jcaf.2002.127771","article-title":"Asthma, \u03b2-agonists, and development of congestive heart failure: results of the ABCHF study","volume":"8","author":"Sengstock","year":"2002","journal-title":"J. Card. Fail."},{"issue":"2","key":"10.1016\/j.rmed.2019.04.001_bib32","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jemermed.2007.11.056","article-title":"Should acute treatment with inhaled beta agonists be withheld from patients with dyspnea who may have heart failure?","volume":"40","author":"Maak","year":"2011","journal-title":"J. Emerg. Med."},{"issue":"3","key":"10.1016\/j.rmed.2019.04.001_bib33","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.hrtlng.2012.11.007","article-title":"Bronchodilator responsiveness in patients with chronic heart failure","volume":"42","author":"Minasian","year":"2013","journal-title":"Heart Lung"},{"issue":"7","key":"10.1016\/j.rmed.2019.04.001_bib34","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/s40265-017-0731-3","article-title":"Management of chronic obstructive pulmonary disease in patients with cardiovascular diseases","volume":"77","author":"Cazzola","year":"2017","journal-title":"Drugs"},{"issue":"1","key":"10.1016\/j.rmed.2019.04.001_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pupt.2009.10.001","article-title":"Pharmacological modulation of beta-adrenoceptor function in patients with coexisting chronic obstructive pulmonary disease and chronic heart failure","volume":"23","author":"Matera","year":"2010","journal-title":"Pulm. Pharmacol. Therapeut."},{"issue":"7369","key":"10.1016\/j.rmed.2019.04.001_bib36","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/S0140-6736(64)92617-0","article-title":"Effect of a beta-adrenergic-blocking agent, propranolol, on asthmatics","volume":"2","author":"McNeill","year":"1964","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.rmed.2019.04.001_bib37","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1378\/chest.13-1235","article-title":"Adverse respiratory effect of acute \u03b2-blocker exposure in asthma: a systematic review and meta-analysis of randomized controlled trials","volume":"145","author":"Morales","year":"2014","journal-title":"Chest"},{"issue":"14","key":"10.1016\/j.rmed.2019.04.001_bib38","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.1111\/bph.13148","article-title":"Effects of chronic treatment with the new ultra-long-acting \u03b22-adrenoceptor agonist indacaterol alone or in combination with the \u03b21-adrenoceptor blocker metoprolol on cardiac remodelling","volume":"172","author":"Rinaldi","year":"2015","journal-title":"Br. J. Pharmacol."},{"issue":"11","key":"10.1016\/j.rmed.2019.04.001_bib39","doi-asserted-by":"crossref","first-page":"A868","DOI":"10.1016\/S0735-1097(18)31409-8","article-title":"Effect if combined beta-blocker and beta-agonist use on clinical outcomes among Medicaid beneficiaries with coexisting heart failure and asthma [abstract]","volume":"71","author":"Adedinsewo","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"issue":"7","key":"10.1016\/j.rmed.2019.04.001_bib40","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1136\/thx.56.7.567","article-title":"Cardiovascular side effects of inhaled salbutamol in hypoxic asthmatic patients","volume":"56","author":"Burggraaf","year":"2001","journal-title":"Thorax"},{"key":"10.1016\/j.rmed.2019.04.001_bib41","first-page":"95","article-title":"Asthma-related sudden death: clinicopathological features in 14 cases","volume":"3","author":"Hiquet","year":"2012","journal-title":"Rev. Med. Leg."},{"issue":"7","key":"10.1016\/j.rmed.2019.04.001_bib42","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.amjcard.2008.05.029","article-title":"Risk of cardiac events in patients with asthma and long-QT syndrome treated with beta2 agonists","volume":"102","author":"Thottathil","year":"2008","journal-title":"Am. J. Cardiol."},{"issue":"1","key":"10.1016\/j.rmed.2019.04.001_bib43","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jaip.2015.07.009","article-title":"Hypertension and asthma: a comorbid relationship","volume":"4","author":"Christiansen","year":"2016","journal-title":"J. Allergy Clin. Immunol. Pract."},{"issue":"3","key":"10.1016\/j.rmed.2019.04.001_bib44","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/0016-5085(90)90945-W","article-title":"Most asthmatics have gastroesophageal reflux with or without bronchodilator therapy","volume":"99","author":"Sontag","year":"1990","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.rmed.2019.04.001_bib45","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/j.1600-0773.1990.tb00841.x","article-title":"The actions of some beta-receptor agonists and xanthines on isolated muscle strips from the human oesophago-gastric junction","volume":"67","author":"T\u00f8ttrup","year":"1990","journal-title":"Pharmacol. Toxicol."},{"key":"10.1016\/j.rmed.2019.04.001_bib46","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1378\/chest.120.4.1184","article-title":"The effects of an inhaled beta2-adrenergic agonist on lower esophageal function: a dose-response study","volume":"120","author":"Crowell","year":"2001","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.rmed.2019.04.001_bib47","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/BF00561363","article-title":"Influence of theophylline on gastro-oesophageal reflux and asthma","volume":"35","author":"Ekstr\u00f6m","year":"1988","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"9","key":"10.1016\/j.rmed.2019.04.001_bib48","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1164\/rccm.200110-033OC","article-title":"Effects of bronchial obstruction on lower esophageal sphincter motility and gastroesophageal reflux in patients with asthma","volume":"166","author":"Zerbib","year":"2002","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"10","key":"10.1016\/j.rmed.2019.04.001_bib49","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1007\/s11605-016-3192-1","article-title":"Inhaled beta agonist bronchodilator does Not Affect Trans-diaphragmatic pressure gradient but decreases lower esophageal sphincter retention pressure in patients with chronic obstructive pulmonary disease (COPD) and gastroesophageal reflux disease (GERD)","volume":"20","author":"Del Grande","year":"2016","journal-title":"J. Gastrointest. Surg."},{"issue":"2","key":"10.1016\/j.rmed.2019.04.001_bib50","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1517\/14740338.7.2.173","article-title":"The effect of anticholinergic agents on gastro-oesophageal reflux and related disorders","volume":"7","author":"van Soest","year":"2008","journal-title":"Expert Opin. Drug Saf."},{"issue":"6","key":"10.1016\/j.rmed.2019.04.001_bib51","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1183\/09031936.00139909","article-title":"Tiotropium reduction of lung inflammation in a model of chronic gastro-oesophageal reflux","volume":"35","author":"Cui","year":"2010","journal-title":"Eur. Respir. J."},{"issue":"9","key":"10.1016\/j.rmed.2019.04.001_bib52","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1517\/14656566.9.9.1531","article-title":"Long-acting \u03b22 agonists in asthma and allergic rhinitis","volume":"9","author":"Matera","year":"2008","journal-title":"Expert Opin. Pharmacother."},{"issue":"Pt 1","key":"10.1016\/j.rmed.2019.04.001_bib53","first-page":"44","article-title":"The anti-allergic effect of \u03b2-agonist agent fenoterol in the nose","volume":"128","author":"Borum","year":"1983","journal-title":"Eur. J. Respir. Dis."},{"issue":"12","key":"10.1016\/j.rmed.2019.04.001_bib54","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1034\/j.1398-9995.2000.00830.x","article-title":"Intranasal \u03b2-agonist in allergic rhinitis","volume":"55","author":"Holt","year":"2000","journal-title":"Allergy"},{"issue":"6 Pt 2","key":"10.1016\/j.rmed.2019.04.001_bib55","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/0091-6749(92)90125-L","article-title":"The anticholinergic treatment of allergic perennial rhinitis","volume":"90","author":"Georgitis","year":"1992","journal-title":"J. Allergy Clin. Immunol."},{"issue":"2","key":"10.1016\/j.rmed.2019.04.001_bib56","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/0091-6749(92)90078-G","article-title":"Ipratropium bromide aqueous nasal spray for patients with perennial allergic rhinitis: a study of its effect on their symptoms, quality of life, and nasal cytology","volume":"90","author":"Meltzer","year":"1992","journal-title":"J. Allergy Clin. Immunol."},{"issue":"1","key":"10.1016\/j.rmed.2019.04.001_bib57","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2500\/108854198778557962","article-title":"The anticholinergic agent, ipratropium bromide, is useful in the treatment of rhinorrhea associated with perennial allergic rhinitis","volume":"2","author":"Kaiser","year":"1998","journal-title":"Allergy Asthma Proc."},{"issue":"5","key":"10.1016\/j.rmed.2019.04.001_bib58","doi-asserted-by":"crossref","first-page":"6558","DOI":"10.3892\/mmr.2017.7411","article-title":"Effects of anticholinergic agent on miRNA profiles and transcriptomes in a murine model of allergic rhinitis","volume":"16","author":"Hou","year":"2017","journal-title":"Mol. Med. Rep."},{"issue":"3","key":"10.1016\/j.rmed.2019.04.001_bib59","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1378\/chest.124.3.795","article-title":"Body mass index and asthma severity among adults presenting to the emergency department","volume":"124","author":"Thomson","year":"2003","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.rmed.2019.04.001_bib60","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1378\/chest.14-2689","article-title":"Obesity and bronchodilator response in black and Hispanic children and adolescents with asthma","volume":"147","author":"McGarry","year":"2015","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.rmed.2019.04.001_bib61","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.jaci.2011.01.036","article-title":"A high-fat challenge increases airway inflammation and impairs bronchodilator recovery in asthma","volume":"127","author":"Wood","year":"2011","journal-title":"J. Allergy Clin. Immunol."},{"issue":"1","key":"10.1016\/j.rmed.2019.04.001_bib62","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s12931-018-0741-z","article-title":"Modulation of human airway smooth muscle biology by human adipocytes","volume":"19","author":"Giesler","year":"2018","journal-title":"Respir. Res."},{"issue":"7","key":"10.1016\/j.rmed.2019.04.001_bib63","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1080\/02770900600859123","article-title":"Effect of obesity on clinical presentation and response to treatment in asthma","volume":"43","author":"Dixon","year":"2006","journal-title":"J. Asthma"},{"issue":"6 Suppl","key":"10.1016\/j.rmed.2019.04.001_bib64","doi-asserted-by":"crossref","first-page":"S313","DOI":"10.1067\/mai.2002.129702","article-title":"\u03b2-Agonists and metabolism","volume":"110","author":"Philipson","year":"2002","journal-title":"J. Allergy Clin. Immunol."},{"issue":"1","key":"10.1016\/j.rmed.2019.04.001_bib65","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0753-3322(90)90069-L","article-title":"Glucose metabolism and beta receptor function in atopic asthmatics","volume":"44","author":"Karnik","year":"1990","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.rmed.2019.04.001_bib66","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.kint.2017.03.024","article-title":"\u03b22-adrenergic receptors in inflammation and vascular complications of diabetes","volume":"92","author":"Galvan","year":"2017","journal-title":"Kidney Int."},{"issue":"6","key":"10.1016\/j.rmed.2019.04.001_bib67","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1007\/s00592-014-0584-0","article-title":"Diabetes mellitus among outpatients with COPD attending a university hospital","volume":"51","author":"Rogliani","year":"2014","journal-title":"Acta Diabetol."},{"issue":"2","key":"10.1016\/j.rmed.2019.04.001_bib68","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1165\/rcmb.2013-0452OC","article-title":"Hyperinsulinemia potentiates airway responsiveness to parasympathetic nerve stimulation in obese rats","volume":"51","author":"Nie","year":"2014","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"1","key":"10.1016\/j.rmed.2019.04.001_bib69","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1164\/rccm.201501-0037OC","article-title":"Stress and bronchodilator response in children with asthma","volume":"192","author":"Brehm","year":"2015","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"6","key":"10.1016\/j.rmed.2019.04.001_bib70","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0179091","article-title":"Self-reported racial\/ethnic discrimination and bronchodilator response in African American youth with asthma","volume":"12","author":"Carlson","year":"2017","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.rmed.2019.04.001_bib71","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jaip.2015.10.004","article-title":"Depression, asthma, and bronchodilator response in a nationwide study of US adults","volume":"4","author":"Han","year":"2016","journal-title":"J. Allergy Clin. Immunol. Pract."},{"issue":"2","key":"10.1016\/j.rmed.2019.04.001_bib72","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/PSY.0b013e3181907012","article-title":"A review of candidate pathways underlying the association between asthma and major depressive disorder","volume":"71","author":"Van Lieshout","year":"2009","journal-title":"Psychosom. Med."},{"issue":"7","key":"10.1016\/j.rmed.2019.04.001_bib73","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.rmed.2011.10.023","article-title":"Association between asthma medications and suicidal ideation in adult asthmatics","volume":"106","author":"Favreau","year":"2012","journal-title":"Respir. Med."},{"key":"10.1016\/j.rmed.2019.04.001_bib74","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.pupt.2018.08.005","article-title":"A proposed scheme to cope with comorbidities in asthma","volume":"52","author":"Marques de Mello","year":"2018","journal-title":"Pulm. Pharmacol. Therapeut."},{"issue":"11","key":"10.1016\/j.rmed.2019.04.001_bib75","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1016\/j.mayocp.2017.08.005","article-title":"Practical considerations for the diagnosis and management of asthma in older adults","volume":"92","author":"Yawn","year":"2017","journal-title":"Mayo Clin. Proc."}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611119300988?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611119300988?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T11:49:22Z","timestamp":1760615362000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611119300988"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":75,"alternative-id":["S0954611119300988"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2019.04.001","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bronchodilators in subjects with asthma-related comorbidities","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2019.04.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}